Sustainable And Ethical VMS Will Drive Consumer Health M&A In 2024

Dietary supplement brands with sustainable and ethical credentials are expected to be popular M&A targets for consumer health firms in 2024, but macroeconomic conditions will likely keep overall deal activity relatively low. 

• Source: Shutterstock

M&A activity in the consumer health market was relatively subdued in 2023 with companies favoring bolt-on opportunities over transformational deals.

More from Europe

More from Geography

Alliance Pharma Set To Be Snapped Up By Private Equity

 
• By 

Offer valuing struggling UK consumer health player Alliance at £350m has the backing of the company's board of directors.

EU Probiotics Deadlock: Ombudsman Finds ‘No Maladministration’ By The Commission

 
• By 

In response to an IPA Europe complaint, European Ombudsman Emily O’Reilly finds that the Commission’s interpretation of EU food legislation in relation to probiotics is “reasonable and in line with the main goal of this legislation, which is to ensure a high level of consumer protection.”

Haleon Completes Deal To Grow Stake In China JV

 
• By 

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.